Cargando…

Prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis

INTRODUCTION: High morbidity and mortality rates in patients with severe acute pancreatitis are mainly caused by bacterial superinfection of pancreatic necrosis and subsequent sepsis. The benefit of early prophylactic antibiotics remains controversial because clinical studies performed to date were...

Descripción completa

Detalles Bibliográficos
Autores principales: Fritz, Stefan, Hartwig, Werner, Lehmann, Ronny, Will-Schweiger, Katja, Kommerell, Mechthild, Hackert, Thilo, Schneider, Lutz, Büchler, Markus W, Werner, Jens
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646352/
https://www.ncbi.nlm.nih.gov/pubmed/19014609
http://dx.doi.org/10.1186/cc7118
_version_ 1782164853616541696
author Fritz, Stefan
Hartwig, Werner
Lehmann, Ronny
Will-Schweiger, Katja
Kommerell, Mechthild
Hackert, Thilo
Schneider, Lutz
Büchler, Markus W
Werner, Jens
author_facet Fritz, Stefan
Hartwig, Werner
Lehmann, Ronny
Will-Schweiger, Katja
Kommerell, Mechthild
Hackert, Thilo
Schneider, Lutz
Büchler, Markus W
Werner, Jens
author_sort Fritz, Stefan
collection PubMed
description INTRODUCTION: High morbidity and mortality rates in patients with severe acute pancreatitis are mainly caused by bacterial superinfection of pancreatic necrosis and subsequent sepsis. The benefit of early prophylactic antibiotics remains controversial because clinical studies performed to date were statistically underpowered. Thus, the aim of this study was to evaluate on-demand versus prophylactic antibiotic treatment in a standardised experimental model. METHODS: Treatment groups received meropenem either therapeutically 24 hours after induction of necrotising pancreatitis or prophylactically before development of pancreatic superinfection. At 24 and 72 hours, pancreatic injury was investigated by histology and translocation by bacterial cultures of pancreatic tissue and mesenteric lymph nodes. Septic complications were evaluated by blood cultures and survival. RESULTS: Without antibiotic treatment, pancreatic superinfection was observed in almost all cases after induction of necrotising pancreatitis. The 72-hour-mortality rate was 42.9% and bacterial infection of mesenteric lymph nodes and bacteraemia was found in 87.5% of the surviving animals. Therapeutic administration of meropenem on-demand reduced bacteraemia to 50% and mortality to 27.3%. However, prophylactic antibiotic treatment significantly reduced bacteraemia to 25.0% (p = 0.04) and pancreatic superinfection as well as mortality to 0% (p < 0.001 and p = 0.05, respectively) compared with controls. CONCLUSIONS: In the present study both prophylactic and delayed antibiotic treatment on-demand reduced septic complications in a standardised setting of experimental necrotising pancreatitis. However, pancreatic superinfection, bacteraemia and mortality rates were reduced significantly by early treatment. Thus, in the absence of statistically relevant and well-designed clinical trials, the study demonstrates that prophylactic antibiotic treatment is superior to antibiotic treatment on-demand.
format Text
id pubmed-2646352
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26463522009-02-24 Prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis Fritz, Stefan Hartwig, Werner Lehmann, Ronny Will-Schweiger, Katja Kommerell, Mechthild Hackert, Thilo Schneider, Lutz Büchler, Markus W Werner, Jens Crit Care Research INTRODUCTION: High morbidity and mortality rates in patients with severe acute pancreatitis are mainly caused by bacterial superinfection of pancreatic necrosis and subsequent sepsis. The benefit of early prophylactic antibiotics remains controversial because clinical studies performed to date were statistically underpowered. Thus, the aim of this study was to evaluate on-demand versus prophylactic antibiotic treatment in a standardised experimental model. METHODS: Treatment groups received meropenem either therapeutically 24 hours after induction of necrotising pancreatitis or prophylactically before development of pancreatic superinfection. At 24 and 72 hours, pancreatic injury was investigated by histology and translocation by bacterial cultures of pancreatic tissue and mesenteric lymph nodes. Septic complications were evaluated by blood cultures and survival. RESULTS: Without antibiotic treatment, pancreatic superinfection was observed in almost all cases after induction of necrotising pancreatitis. The 72-hour-mortality rate was 42.9% and bacterial infection of mesenteric lymph nodes and bacteraemia was found in 87.5% of the surviving animals. Therapeutic administration of meropenem on-demand reduced bacteraemia to 50% and mortality to 27.3%. However, prophylactic antibiotic treatment significantly reduced bacteraemia to 25.0% (p = 0.04) and pancreatic superinfection as well as mortality to 0% (p < 0.001 and p = 0.05, respectively) compared with controls. CONCLUSIONS: In the present study both prophylactic and delayed antibiotic treatment on-demand reduced septic complications in a standardised setting of experimental necrotising pancreatitis. However, pancreatic superinfection, bacteraemia and mortality rates were reduced significantly by early treatment. Thus, in the absence of statistically relevant and well-designed clinical trials, the study demonstrates that prophylactic antibiotic treatment is superior to antibiotic treatment on-demand. BioMed Central 2008 2008-11-16 /pmc/articles/PMC2646352/ /pubmed/19014609 http://dx.doi.org/10.1186/cc7118 Text en Copyright © 2008 Fritz et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Fritz, Stefan
Hartwig, Werner
Lehmann, Ronny
Will-Schweiger, Katja
Kommerell, Mechthild
Hackert, Thilo
Schneider, Lutz
Büchler, Markus W
Werner, Jens
Prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis
title Prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis
title_full Prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis
title_fullStr Prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis
title_full_unstemmed Prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis
title_short Prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis
title_sort prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646352/
https://www.ncbi.nlm.nih.gov/pubmed/19014609
http://dx.doi.org/10.1186/cc7118
work_keys_str_mv AT fritzstefan prophylacticantibiotictreatmentissuperiortotherapyondemandinexperimentalnecrotisingpancreatitis
AT hartwigwerner prophylacticantibiotictreatmentissuperiortotherapyondemandinexperimentalnecrotisingpancreatitis
AT lehmannronny prophylacticantibiotictreatmentissuperiortotherapyondemandinexperimentalnecrotisingpancreatitis
AT willschweigerkatja prophylacticantibiotictreatmentissuperiortotherapyondemandinexperimentalnecrotisingpancreatitis
AT kommerellmechthild prophylacticantibiotictreatmentissuperiortotherapyondemandinexperimentalnecrotisingpancreatitis
AT hackertthilo prophylacticantibiotictreatmentissuperiortotherapyondemandinexperimentalnecrotisingpancreatitis
AT schneiderlutz prophylacticantibiotictreatmentissuperiortotherapyondemandinexperimentalnecrotisingpancreatitis
AT buchlermarkusw prophylacticantibiotictreatmentissuperiortotherapyondemandinexperimentalnecrotisingpancreatitis
AT wernerjens prophylacticantibiotictreatmentissuperiortotherapyondemandinexperimentalnecrotisingpancreatitis